https://www.selleckchem.com/pr....oducts/Vorinostat-sa
At baseline 80 (67%) patients were successfully physical active, 39 (33%) were not. NTproBNP was lower in active patients. During 1-year follow-up physical active patients stayed active 72 (90%) at 12weeks, 72 (90%) at 1year. Inactive patients became active at 12weeks 25 (64%) patients and 30 (77%) at 1year. No benefits were seen on sinus rhythm maintenance and QoL for successful physical active patients. In patients with persistent AF and moderate heart failure participation in CR contributes to improve and to maintain physical